San Antonio, June 20, 2012 (GLOBE NEWSWIRE) -- Keraplast Technologies, LLC the developer of ReplicineTM Functional Keratin®Advanced Wound care products announced today having entered an agreement with Gramatek Ltd, for distribution of their advanced wound care products to Hospitals and wound care centers throughout Turkey. Partnering with Gramatek provides Keraplast access to Hospitals, Clinics and strategic Points of service centers throughout key regional areas of Turkey, said Michael Espensen, CEO of Keraplast Technologies, LLC. “We are extremely pleased to enter into this agreement with such an esteemed organization and to provide members served by Gramatek with our paradigm changing line of Replicine™ Functional Keratin® products. Clinicians in many regions of the world, including the USA, Europe, Australia, New Zealand, South Africa, and now Turkey can utilize the latest clinical advancement in wound healing. The global interest in kerasorb®, keramatrix®, keragel™ and keragelT™ is expanding quickly and were putting in a strong network to provide good support wherever the products are in demand”.
